Soleno Therapeutics, Inc.SLNONASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank92
3Y CAGR+38.6%
5Y CAGR+11.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+38.6%/yr
vs +20.8%/yr prior
5Y CAGR
+11.9%/yr
Recent acceleration
Acceleration
+17.8pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $40.63M | -48.3% |
| 2024 | $78.57M | +211.9% |
| 2023 | $25.19M | +65.0% |
| 2022 | $15.27M | -28.8% |
| 2021 | $21.45M | -7.5% |
| 2020 | $23.19M | +42.6% |
| 2019 | $16.27M | +126.6% |
| 2018 | $7.18M | +133.9% |
| 2017 | $3.07M | -40.8% |
| 2016 | $5.18M | - |